Mina Sooch - 19 May 2022 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role
President and CEO, Director
Signature
/s/ Emily J. Johns, by Power of Attorney
Issuer symbol
IRD
Transactions as of
19 May 2022
Net transactions value
+$51,179
Form type
4
Filing time
23 May 2022, 16:58:51 UTC
Previous filing
01 Feb 2022
Next filing
08 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCUP Common Stock Purchase $25,879 +12,500 +3.1% $2.07 412,522 19 May 2022 Direct F1
transaction OCUP Common Stock Purchase $25,300 +12,500 +3% $2.02 425,022 20 May 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.045 to $2.10. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
F2 The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.015 to $2.025. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.